Cargando…
Precision Medicine in Lymphoma by Innovative Instrumental Platforms
In recent years, many efforts have been addressed to the growing field of precision medicine in order to offer individual treatments to every patient on the basis of his/her genetic background. Formerly adopted to achieve new disease classifications as it is still done, innovative platforms, such as...
Autores principales: | Di Paolo, Antonello, Arrigoni, Elena, Luci, Giacomo, Cucchiara, Federico, Danesi, Romano, Galimberti, Sara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928138/ https://www.ncbi.nlm.nih.gov/pubmed/31921674 http://dx.doi.org/10.3389/fonc.2019.01417 |
Ejemplares similares
-
Sunitinib in Metastatic Renal Cell Carcinoma: The Pharmacological Basis of the Alternative 2/1 Schedule
por: Di Paolo, Antonello, et al.
Publicado: (2017) -
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment
por: Arrigoni, Elena, et al.
Publicado: (2018) -
Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine
por: Hapuarachchige, Sudath, et al.
Publicado: (2020) -
Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation
por: Bruno, Rossella, et al.
Publicado: (2021) -
Innovation and Precision Medicine Applied to a Medullary Thyroid Cancer: A Clinical Case
por: Guedes, Helena, et al.
Publicado: (2023)